Bionomics and MSD Hosting Cognition and Alzheimer’s Symposium Featuring Australian and US …

ADELAIDE, Australia, Nov. 13, 2015 /PRNewswire/ — Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, will co-host a one-day symposium in Adelaide at the Crowne Plaza, Hindmarsh Square on Monday 16 November 2015 on Drug Discovery and Development for Cognition and Alzheimer’s Disease featuring Australian and US experts.Bionomics has combined with Merck & Co Inc., of Kenilworth NJ (known as Merck, Sharp and Dohme or MSD, outside the United States and Canada) to arrange the event.This is the third annual Bionomics – MSD symposium and will be the biggest to date with over 200 registrations. Attendees include researchers, medical personnel and patient support groups as well as investors and…


Link to Full Article: Bionomics and MSD Hosting Cognition and Alzheimer’s Symposium Featuring Australian and US …